Nchi: Uingereza
Lugha: Kiingereza
Chanzo: MHRA (Medicines & Healthcare Products Regulatory Agency)
Isosorbide mononitrate
Genus Pharmaceuticals Ltd
C01DA14
Isosorbide mononitrate
60mg
Modified-release tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02060100; GTIN: 5030451001436
PATIENT INFORMATION LEAFLET XISMOX ® 60 XL PROLONGED RELEASE TABLETS (ISOSORBIDE MONONITRATE) PLEASE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING XISMOX 60 XL BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. This medicine is available without prescription. However, you still need to use XISMOX 60 XL Prolonged Release Tablets carefully to get the best results from it. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. WHAT XISMOX 60 XL IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE XISMOX 60 XL 3. HOW TO TAKE XISMOX 60 XL 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE XISMOX 60 XL 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT XISMOX 60 XL IS AND WHAT IT IS USED FOR The name of your medicine is XISMOX 60 XL Prolonged Release Tablets (referred to as XISMOX 60 XL) throughout this leaflet. XISMOX 60 XL contains the active ingredient Isosorbide Mononitrate, which belongs to a group of medicines called nitrates. IT IS USED TO PREVENT AN ATTACK OF ANGINA PECTORIS (CHEST PAIN) FROM HAPPENING. Angina is a crushing pain or tightness in the chest, although the pain may also be felt in the neck or arm. The pain happens when the muscle in the heart does not receive enough oxygen for the work it has to do. XISMOX 60 XL works by IMPROVING THE SUPPLY OF BLOOD AND OXYGEN to the heart muscle. The tablets will release your medicine slowly and will treat your condition throughout the day. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE XISMOX 60 XL DO NOT use these tablets TO TREAT SUDDEN CHEST PAIN (acute agina). INSTEAD SEEK IMMEDIATE MEDICAL ATTENTION. These tablets work too slowly to treat this and are only used to prevent symptoms of angina from happening. DO NOT TAKE XISMOX 60 XL IF: • you are allergic (hypersensitive) to isosorbide mononitrate or any Soma hati kamili
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT ISIB 60 XL Prolonged Release Tablets XISMOX 60 XL Prolonged Release Tablets TARDISC XL 60 Prolonged Release Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Isosorbide mononitrate 60 mg Excipients with a known effect: Each tablets contains approximately 98.5 mg of lactose Each tablet contains approximately 43 mg of sucrose For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Prolonged Release Tablets Light yellow, biconvex, oval-shaped, scored on both sides and marked "DX 31" on one side. The tablet can be divided into equal doses. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Prophylactic treatment of angina pectoris. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY ADULTS The recommeded dose is one 60 mg tablet, once daily, given in the morning. The dose may be increased to 120 mg (two tablets) daily, both to be taken once daily in the morning. This will produce effective nitrate blood levels during the day with low blood levels at night to prevent the development of tolerance. The dose can be titrated, to minimize the possibility of headache, by initiating treatment with 30mg (half a tablet) for the first 2-4 days. Note that isosorbide mononitrate is not indicated for the relief of acute attacks, in the event of an acute attack, sublingual or buccal glyceryl trinitrate tablets should be used. PAEDIATRIC POPULATION The safety and efficacy of this medicine in children has not been established. ELDERLY No evidence of a need for routine dosage adjustment in the elderly has been found, but special care may be needed in those with increased susceptibility to hypotension or marked hepatic or renal insufficiency. There is a risk of tolerance developing when nitrate therapy is given. For this reason it is important that the tablets are taken once a day to achieve an interval with low nitrate concentration, thereby reducing the risk of tolerance development. When necessary the product may be used in combin Soma hati kamili